Article Sidebar
Published:
Mar 12, 2024DOI:
10.4314/tjpr.v23i2.3Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Anacardic acid inhibits the proliferation and inflammation of HaCaT cells induced by TNF-α via the regulation of NF-κB pathway
Abstract
Purpose: To determine the effect of anacardic acid on HaCaT cells in vitro and to elucidate its molecular action.
Methods: HaCaT cells were incubated in varying concentrations of anacardic acid (10 to 50 μM). To model psoriasis, the cells were treated with tumor necrosis factor-α (TNF-α); cell viability was gauged by CCK-8 assay. Apoptosis was determined, and Bcl-2, Bax, p65, p-p65, p-IκBα and IκBα by Western blot. Levels of pro-inflammatory cytokines were evaluated by enzyme-linked immunosorbent assay (ELISA).
Results: Anacardic acid resulted in reduced HaCaT cell viability and increased cell apoptosis in a concentration-dependent manner (p < 0.05). It also curtailed TNF-α-mediated inflammatory responses and downregulated the NF-κB signaling axis.
Conclusion: The results indicate that anacardic acid impedes HaCaT cell growth and inflammatory cytokine production by interfering with NF-κB signal transduction, and may influence the development of AA-based therapies for psoriasis.
